MercadoLibre Inc. (MELI)vsMedirom Healthcare Technologies Inc (MRM)
MELI
MercadoLibre Inc.
$1,673.09
-0.44%
CONSUMER CYCLICAL · Cap: $92.98B
MRM
Medirom Healthcare Technologies Inc
$0.36
-2.85%
CONSUMER CYCLICAL · Cap: $2.74M
Smart Verdict
WallStSmart Research — data-driven comparison
MercadoLibre Inc. generates 336% more annual revenue ($35.18B vs $8.07B). MELI leads profitability with a 5.3% profit margin vs 0.5%. MRM trades at a lower P/E of 0.9x. MELI earns a higher WallStSmart Score of 58/100 (C).
MELI
Buy58
out of 100
Grade: C
MRM
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+64.4%
Fair Value
$5665.85
Current Price
$1673.09
$3992.76 discount
Margin of Safety
+70.1%
Fair Value
$4.35
Current Price
$0.36
$3.99 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 49.8% year-over-year
Large-cap with strong market position
Every $100 of equity generates 24 in profit
Growing faster than its price suggests
Generating 3.2B in free cash flow
Attractively priced relative to earnings
Every $100 of equity generates 64 in profit
Reasonable price relative to book value
Earnings expanding 27.8% YoY
Areas to Watch
Trading at 10.8x book value
5.3% margin — thin
Elevated debt levels
Weak financial health signals
Smaller company, higher risk/reward
0.5% margin — thin
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MELI
The strongest argument for MELI centers on Revenue Growth, Market Cap, Return on Equity. Revenue growth of 49.8% demonstrates continued momentum. PEG of 1.00 suggests the stock is reasonably priced for its growth.
Bull Case : MRM
The strongest argument for MRM centers on P/E Ratio, Return on Equity, Price/Book.
Bear Case : MELI
The primary concerns for MELI are Price/Book, Profit Margin, Debt/Equity. A P/E of 50.5x leaves little room for execution misses. Debt-to-equity of 1.68 is elevated, increasing financial risk.
Bear Case : MRM
The primary concerns for MRM are Market Cap, Profit Margin, Debt/Equity. Debt-to-equity of 1.75 is elevated, increasing financial risk. Thin 0.5% margins leave little buffer for downturns.
Key Dynamics to Monitor
MELI profiles as a hypergrowth stock while MRM is a value play — different risk/reward profiles.
MELI carries more volatility with a beta of 1.31 — expect wider price swings.
MELI is growing revenue faster at 49.8% — sustainability is the question.
MELI generates stronger free cash flow (3.2B), providing more financial flexibility.
Bottom Line
MELI scores higher overall (58/100 vs 41/100) and 49.8% revenue growth. MRM offers better value entry with a 70.1% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MercadoLibre Inc.
CONSUMER CYCLICAL · INTERNET RETAIL · USA
MercadoLibre, Inc. operates online trading platforms in Latin America. The company is headquartered in Buenos Aires, Argentina.
Medirom Healthcare Technologies Inc
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
MEDIROM Healthcare Technologies Inc. provides comprehensive healthcare services in Japan. The company is headquartered in Tokyo, Japan.
Visit Website →Compare with Other INTERNET RETAIL Stocks
Want to dig deeper into these stocks?